The Trading of Sex for Drugs or Money and HIV Seropositivity Among Female Intravenous Drug Users

Overview

Journal Am J Public Health

Specialty Public Health

Date 1994 Mar 1

PMID 8129052

Citations 44

Authors

J Astemborski

D Vlahov

D Warren

L Solomon

K E Nelson

Affiliations

Soon will be listed here.

Abstract

Objectives: Data from 538 women in a cohort study recruited in 1988-1989 were analyzed to determined whether trading sex for drugs or money was independently associated with human immunodeficiency virus (HIV) seroprevalence in a population of female intravenous drug users.

Methods: The women were grouped according to the number of partners with whom they reported trading sex for drugs or money during the previous 10 years: none, 1 through 49 (low), or 50 or more (high); the prevalence of HIV seropositivity in the three groups was 23.2%, 23.7%, and 47.6%, respectively. Logistic regression was used to compare the low- and high-trade groups separately with the group that reported no trading.

Results: Low trading was not associated with seroprevalent HIV infection. In a multivariate model, high trading (compared with no trading) was significantly associated with HIV seropositivity after adjustment for cocaine use, history of sexually transmitted diseases, and duration of intravenous drug use.

Conclusions: These data indicate that, among intravenous drug-using women, high levels of trading sex for drugs or money were independently associated with HIV infection. This group needs to be targeted for further intensive intervention.

Citing Articles

Assessing awareness and utilisation of pre-exposure prophylaxis for HIV prevention among women who inject drugs in Lagos, Nigeria: a cross-sectional study.

Onigbogi O, Eghaghe O, Onigbogi M, Ojo O, Babalola O BMJ Public Health. 2025; 2(1):e000293.

PMID: 40018130 PMC: 11812754. DOI: 10.1136/bmjph-2023-000293.

Molecular epidemiology of HIV-1 among adult female sex workers at the Guatemala-Mexico border.

Springfield O, Brouwer K, Avila-Rios S, Morales-Miranda S, Mehta S Glob Public Health. 2023; 18(1):2278873.

PMID: 37944916 PMC: 10808948. DOI: 10.1080/17441692.2023.2278873.

Factors Associated with Exchange Sex Among Cisgender Persons Who Inject Drugs: Women and MSM-23 U.S. Cities, 2018.

Rushmore J, Buchacz K, Broz D, Agnew-Brune C, Johnson Jones M, Cha S AIDS Behav. 2022; 27(1):51-64.

PMID: 35750928 PMC: 10208374. DOI: 10.1007/s10461-022-03743-0.

Cultivating PEARL (Promoting Empowerment and Risk Reduction): Formative Research for a PrEP Intervention Among Female Sex Workers in Baltimore, Maryland.

Glick J, Jivapong B, Russo R, Pelaez D, Piser R, Footer K AIDS Behav. 2022; 26(8):2664-2675.

PMID: 35124751 PMC: 9885761. DOI: 10.1007/s10461-022-03600-0.

HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.

Walters S, Kral A, Simpson K, Wenger L, Bluthenthal R Subst Use Misuse. 2020; 55(14):2409-2419.

PMID: 32962490 PMC: 7665852. DOI: 10.1080/10826084.2020.1823419.

References

Tirelli U, Vaccher E, Carbone A, De Paoli P, Santini G, Monfardini S . Heterosexual contact is not the predominant mode of HTLV-III transmission among intravenous drug abusers. JAMA. 1986; 255(17):2289. View

Samuels J, Vlahov D, Anthony J, Chaisson R . Measurement of HIV risk behaviors among intravenous drug users. Br J Addict. 1992; 87(3):417-28. DOI: 10.1111/j.1360-0443.1992.tb01942.x. View

Friedland G, Klein R . Transmission of the human immunodeficiency virus. N Engl J Med. 1987; 317(18):1125-35. DOI: 10.1056/NEJM198710293171806. View

Marmor M, Des Jarlais D, Cohen H, Friedman S, Beatrice S, Dubin N . Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS. 1987; 1(1):39-44. View

van den Hoek J, Coutinho R, Van Haastrecht H, van Zadelhoff A, Goudsmit J . Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS. 1988; 2(1):55-60. DOI: 10.1097/00002030-198802000-00010. View

Franceschi S, Tirelli U, Vaccher E, Serraino D, Crovatto M, De Paoli P . Risk factors for HIV infection in drug addicts from the northeast of Italy. Int J Epidemiol. 1988; 17(1):162-7. DOI: 10.1093/ije/17.1.162. View

Chaisson R, Bacchetti P, Osmond D, Brodie B, Sande M, Moss A . Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989; 261(4):561-5. View

van den Hoek J, Van Haastrecht H, Goudsmit J, Coutinho R . HIV infection and STD in drug addicted prostitutes in Amsterdam: potential for heterosexual HIV transmission. Genitourin Med. 1989; 65(3):146-50. PMC: 1194320. DOI: 10.1136/sti.65.3.146. View

Schoenbaum E, Hartel D, Selwyn P, Klein R, Davenny K, Rogers M . Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989; 321(13):874-9. DOI: 10.1056/NEJM198909283211306. View

10.

Williams M . A model of the sexual relations of young i.v. drug users. J Acquir Immune Defic Syndr (1988). 1990; 3(2):192-3. View

11.

Battjes R, Pickens R, Amsel Z, Brown Jr L . Heterosexual transmission of human immunodeficiency virus among intravenous drug users. J Infect Dis. 1990; 162(5):1007-11. DOI: 10.1093/infdis/162.5.1007. View

12.

Vlahov D, Munoz A, Anthony J, Cohn S, Celentano D, Nelson K . Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1990; 132(5):847-56. DOI: 10.1093/oxfordjournals.aje.a115727. View

13.

Salmaso S, Conti S, Sasse H . Drug use and HIV-1 infection: report from the Second Italian Multicenter Study. J Acquir Immune Defic Syndr (1988). 1991; 4(6):607-13. View

14.

Lewis D, Watters J . Sexual risk behavior among heterosexual intravenous drug users: ethnic and gender variations. AIDS. 1991; 5(1):77-83. DOI: 10.1097/00002030-199101000-00011. View

15.

Nelson K, Vlahov D, Cohn S, Odunmbaku M, Lindsay A, Antohony J . Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV). J Infect Dis. 1991; 164(3):457-63. DOI: 10.1093/infdis/164.3.457. View

16.

Saxon A, Calsyn D, Whittaker S, FREEMAN Jr G . Sexual behaviors of intravenous drug users in treatment. J Acquir Immune Defic Syndr (1988). 1991; 4(10):938-44. View

17.

Booth R, Koester S, Brewster J, Weibel W, Fritz R . Intravenous drug users and AIDS: risk behaviors. Am J Drug Alcohol Abuse. 1991; 17(3):337-53. DOI: 10.3109/00952999109027557. View

18.

Chiasson M, Stoneburner R, Hildebrandt D, Ewing W, Telzak E, Jaffe H . Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS. 1991; 5(9):1121-6. DOI: 10.1097/00002030-199109000-00011. View

19.

Anthony J, Vlahov D, Nelson K, Cohn S, Astemborski J, Solomon L . New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol. 1991; 134(10):1175-89. DOI: 10.1093/oxfordjournals.aje.a116021. View

20.

Chirgwin K, DeHovitz J, Dillon S, McCormack W . HIV infection, genital ulcer disease, and crack cocaine use among patients attending a clinic for sexually transmitted diseases. Am J Public Health. 1991; 81(12):1576-9. PMC: 1405272. DOI: 10.2105/ajph.81.12.1576. View